Abstract: Apparatus, systems and methods are disclosed for treating a biological fluid with light. A container of biological fluid is introduced into a fluid treatment chamber where it is contacted with light provided by one or more light sources in proximity to the fluid treatment chamber. A drawer for holding containers of biological fluid introduces the containers into the chamber. Containers for holding the biological fluid are marked by the apparatus to indicate the status of the treatment.
Type:
Grant
Filed:
June 3, 1999
Date of Patent:
May 20, 2003
Assignees:
Baxter International Inc., Cerus Corporation
Inventors:
Kathleen A. Hanley, George D. Cimino, Peter R. H. Stark, Wendy M. Power, Paul A. Franzosa, Daniela Homza Stark, David F. Beittel, Peyton S. Metzel
Abstract: Blood separation systems and methods draw whole blood from a blood donor selected from a population of blood donors. The whole blood of the selected blood donor has a known hematocrit value that varies within the population of blood donors according to morphology of the selected blood donor. The systems and methods operate a pump in the inlet line to convey a volume of whole blood from the donor at a commanded flow rate for processing into plasma constituent and concentrated red blood cells. The systems and methods set the commanded flow rate to vary the volume of whole blood conveyed over time as a function of the known hematocrit value of the selected donor. The systems and methods obtain, after processing the whole blood volume, a targeted volume of concentrated red blood cells, which is substantially constant for the population of blood donors despite variances in known hematocrit values among the donors.
Type:
Grant
Filed:
November 26, 1997
Date of Patent:
June 26, 2001
Assignee:
Baxter International Inc.
Inventors:
Daniel F Bischof, Matthew E Likens, Richard P Goldhaber, Jose C Deniega, Daniel H Duff
Abstract: Platelet suspensions and methods for resuspending platelet concentrates are disclosed. The platelet concentrates are resuspended by combining a platelet concentrate with a hypertonic solution of either sodium chloride or potassium chloride. The resuspended platelets may be stored and/or administered to a patient.
Abstract: Blood processing systems and methods establish on line communication between a container and a source of blood containing leukocytes and platelets, such as a human donor. The systems and methods create a centrifugal field between the source of blood and the container that separates from the blood an unfinished suspension of platelets having a first physiologic characteristic different than the desired physiologic characteristic. The systems and methods pump the unfinished platelet suspension outside the centrifugal field through a finishing device. The finishing device changes the first physiologic characteristic to the desired physiological characteristic, thereby creating the finished platelet suspension. The systems and methods convey the finished platelet suspension from the finishing device directly into the container. The systems and methods function without interrupting the on line communication between the container and the source of blood.
Abstract: Novel blood cell fractionation devices are provided. The device utilizes filters coated with high molecular weight polyethylene oxide derivatives cross-linked to prevent leaching from filter surfaces. These filters have a special efficacy in preventing protein adsorption and cellular adhesion to the membrane filter.
Abstract: A peristaltic pump tube holder includes a body that supports a flexible tubing loop in an erect, outwardly bowed position extending from the body for engagement with a peristaltic pump rotor. The holder also includes a receptacle carrying the body. The receptacle includes a wall forming a chamber that covers the flexible tubing loop and at least partially shields it from contact. The chamber further serves, during engagement between the tubing loop and a peristaltic pump rotor, as a cover for the peristaltic pump rotor.
Type:
Grant
Filed:
April 28, 1997
Date of Patent:
February 9, 1999
Assignee:
Baxter International Inc.
Inventors:
Richard C. Giesler, Myra P. Miles, Susan L. Lovelace, Timothy J. Patno, Richard L. West
Abstract: Blood processing systems and methods establish on line communication between a container and a source of blood containing leukocytes and platelets, such as a human donor. The systems and methods create a centrifugal field between the source of blood and the container that separates from the blood an unfinished suspension of platelets having a first physiologic characteristic different than the desired physiologic characteristic. The systems and methods pump the unfinished platelet suspension outside the centrifugal field through a finishing device. The finishing device changes the first physiologic characteristic to the desired physiological characteristic, thereby creating the finished platelet suspension. The systems and methods convey the finished platelet suspension from the finishing device directly into the container. The systems and methods function without interrupting the on line communication between the container and the source of blood.